Akt Isoforms: A Family Affair in Breast Cancer
Reads0
Chats0
TLDR
In this article, the authors analyzed current literatures on distinct functions of Akt isoforms in breast cancer and proposed an approach to target the Akt signaling pathway for cancer therapy, which is critical to effectively target this pathway.Abstract:
Akt, also known as protein kinase B (PKB), belongs to the AGC family of protein kinases. It acts downstream of the phosphatidylinositol 3-kinase (PI3K) and regulates diverse cellular processes, including cell proliferation, cell survival, metabolism, tumor growth and metastasis. The PI3K/Akt signaling pathway is frequently deregulated in breast cancer and plays an important role in the development and progression of breast cancer. There are three closely related members in the Akt family, namely Akt1(PKBα), Akt2(PKBβ) and Akt3(PKBγ). Although Akt isoforms share similar structures, they exhibit redundant, distinct as well as opposite functions. While the Akt signaling pathway is an important target for cancer therapy, an understanding of the isoform-specific function of Akt is critical to effectively target this pathway. However, our perception regarding how Akt isoforms contribute to the genesis and progression of breast cancer changes as we gain new knowledge. The purpose of this review article is to analyze current literatures on distinct functions of Akt isoforms in breast cancer.read more
Citations
More filters
Journal ArticleDOI
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors.
TL;DR: Heterobifunctional molecules other than PROTACs are introduced, the limitations of existing molecules are summarized, the main challenges are listed, and perspectives for future research directions are proposed, providing insight into alternative design strategies based on substrate-proximity-based targeting.
Journal ArticleDOI
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions.
TL;DR: In this paper , a review of the relationship between PI3K/AKT signaling pathway and factors contributing to initiation and development of various cancers is presented, and therapeutic interventions regulating this signaling pathway have been summarized.
Journal ArticleDOI
Role of protein phosphorylation in cell signaling, disease, and the intervention therapy
Kun Pang,Wei Wang,Jia-xin Qin,Zhenjun Shi,Lin Hao,Yu‐Yang Ma,Haocheng Xu,Zhuo-Xun Wu,Deng Pan,Zhe S Chen,Cong Han +10 more
TL;DR: In this article , the authors analyzed 303 small-molecule protein phosphorylation kinase inhibitors (PKIs) registered and participated in clinical research obtained in a database named Protein Kinase Inhibitor Database (PKIDB), including 68 drugs approved by the Food and Drug Administration of the United States.
Journal ArticleDOI
AKT Serine/Threonine Kinase 2-mediated phosphorylation of Fascin Threonine 403 regulates esophageal cancer progression.
Zhi-Da Zhang,Bing Wen,Da-Jia Li,Dan Deng,Xiaodong Wu,Yinwei Cheng,Lian-Di Liao,Lin Long,Geng Dong,Lian Xu,En Min Li +10 more
TL;DR: In this article , a novel phosphorylation of Fascin Threonine 403 (Fascin-T403) mediated by AKT serine/threonine kinase 2 (AKT2) was studied using mass spectrometry data from esophageal cancer tissues (iProX database: IPX0002501000).
Journal ArticleDOI
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches
TL;DR: Of particular interest are the data showing that miR-29b1-5p counteracts cell proliferation and migration and reduces stemness in breast tumor cells with a triple negative phenotype, and its possible implication in phenotype-specific management of breast tumors.
References
More filters
Journal ArticleDOI
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
Christina A. Gewinner,Zhigang C. Wang,Andrea L. Richardson,Julie Teruya-Feldstein,Dariush Etemadmoghadam,David D.L. Bowtell,Jordi Barretina,William M. Lin,Lucia E. Rameh,Leonardo Salmena,Pier Paolo Pandolfi,Lewis C. Cantley +11 more
TL;DR: It is reported that knocking down the expression of inositol polyphosphate 4-phosphatase type II in human epithelial cells, like knockdown of PTEN, resulted in enhanced Akt activation and anchorage-independent growth and enhanced overall motility, suggesting that INPP4B is a tumor suppressor.
Journal ArticleDOI
Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT.
TL;DR: Results indicate that while Akt can promote tumor progression through increased cell survival mechanisms, it can block breast cancer cell motility and invasion by a mechanism that depends, at least in part, on the NFAT transcription factor.
Journal ArticleDOI
PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.
Thomas Porstmann,Beatrice Griffiths,Yuen-Li Chung,Oona Delpuech,John R. Griffiths,Julian Downward,Almut Schulze +6 more
TL;DR: The data indicate that activation of SREBP by Akt leads to the induction of key enzymes of the cholesterol and fatty acid biosynthesis pathways, and thus membrane lipid biosynthesis.
Journal ArticleDOI
Control of autophagy by oncogenes and tumor suppressor genes.
Maria Chiara Maiuri,Ezgi Tasdemir,Ezgi Tasdemir,Ezgi Tasdemir,Alfredo Criollo,Alfredo Criollo,Alfredo Criollo,Eugenia Morselli,Eugenia Morselli,Eugenia Morselli,Jose Miguel Vicencio,Jose Miguel Vicencio,Jose Miguel Vicencio,Rosa Carnuccio,Guido Kroemer,Guido Kroemer,Guido Kroemer +16 more
TL;DR: The current state-of-the art suggests a complex relationship between cancer and deregulated autophagy that must be disentangled by further in-depth investigation.
Journal ArticleDOI
PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival
TL;DR: This work reports a route by which activated PKB promotes survival in response to DNA insults in vivo, and places PKB downstream of DNA-PK in the DNA damage response signaling cascade, where it provides a prosurvival signal.